financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Marvell Technology, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Marvell Technology, Inc.
Apr 11, 2024 10:29 AM

01:10 PM EDT, 04/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

MRVL hosted its Accelerated Infrastructure for the AI Era event where it highlighted an objective to double its market share by 2028 (10% in 2023), led by share gain in the custom compute and switching markets, which we think has the potential to grow MRVL's revenue by at least 3x-4x in five years. MRVL estimates that its TAM will rise at a 29% CAGR through CY 28 to $75B (estimated $21B in 2023), with accelerated custom compute at a 45%+ CAGR and switching at 15%+. On the connectivity side, AI workloads are demanding a doubling of interconnect speed every two years, or half the time to pre-ChatGPT (2x every four years). On the compute side, we see design wins from existing/new hyperscale customers and greater momentum for next gen nodes aiding demand. MRVL sees AI-related revenue growing to at least $1.5B in FY 25 (2/3 connectivity, 1/3 custom compute) and $2.5B by FY 26, which compares to $550M in FY 24 (all optics driven). This equates to AI revenue growing to over 35% of revenue by FY 26 (10% in FY 24).

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Raises Opinion On Health Care To Marketweight From Underweight
Research Alert: CFRA Raises Opinion On Health Care To Marketweight From Underweight
Oct 8, 2025
01:40 PM EDT, 10/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: After Pfizer Inc. (PFE 26 ****) and the U.S. government struck the first Most Favored Nation (MFN) drug pricing deal to lower drug prices in the U.S., we see policy...
Research Alert: CFRA Lowers Opinion On Real Estate To Underweight From Marketweight
Research Alert: CFRA Lowers Opinion On Real Estate To Underweight From Marketweight
Oct 8, 2025
02:20 PM EDT, 10/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We are lowering our opinion on the Real Estate sector to underweight given its vulnerability to potential disappointment if Fed rate cuts prove less aggressive than market expectations, combined with...
Research Alert: CFRA Reiterates Sell Opinion On Shares Of Ferrari N.v.
Research Alert: CFRA Reiterates Sell Opinion On Shares Of Ferrari N.v.
Oct 9, 2025
10:15 AM EDT, 10/09/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our 12-month target at $350, based on a 2026 P/E of 30x, a justified discount to RACE's 10-year average forward P/E multiple of 40x. Our adjusted EPS estimates...
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Pepsico, Inc.
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Pepsico, Inc.
Oct 9, 2025
01:45 PM EDT, 10/09/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our 12-month target of $170, based on a 2026 P/E of 20.2x, a justified discount to PEP's five-year mean forward P/E of 23.0x. We maintain our adjusted EPS...
Copyright 2023-2025 - www.financetom.com All Rights Reserved